secwatch.observer — SEC 8-K summary
======================================

Issuer:     STRYKER CORP (SYK)
CIK:        0000310764
Form:       8-K
Filed at:   2024-07-30T23:59:59+00:00
Accession:  0000310764-24-000095
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stryker Q2 2024: organic sales +9.0%, adj. EPS $2.81, raises FY guidance
------------------------------------------------------------------------

- Net sales $5.4B (+8.5% reported, +9.0% organic); MedSurg Neuro +9.7% organic, Ortho Spine +8.0% organic.
- Reported EPS $2.14 (+10.9% YoY); adjusted EPS $2.81 (+10.6% YoY); adjusted op. margin 24.6% (+30 bps).
- FY 2024 organic sales growth guidance raised to 9.0%-10.0%; adjusted EPS guidance $11.90-$12.10.
- Adjusted net earnings $1,085M (+11.2%). Guided for modest FX headwind ($0.10-$0.15) on adjusted EPS.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/310764/000031076424000095/0000310764-24-000095-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/310764/000031076424000095/syk-20240730.htm
  HTML page:      https://secwatch.observer/filing/0000310764-24-000095

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer